Sanofi Shares - analyst consensus stays cautious
18.06.2026 - 13:18:42 | ad-hoc-news.de
Edited by ad hoc news Thu Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 13:14 UTC. Details in the imprint.
Sanofi (FR0000127771) has no live-verifiable primary hook in the material provided, so today’s piece centers on the Thursday technical module. The stock also stays in the frame after recent market weakness, with one live quote showing SNY at $42.50 on 06/17/2026.
All news and analysis on Sanofi stock
Read the latest stock coverage, company context, and market data in one place.
What the market is saying
MarketBeat lists a consensus price target of $51.00 for Sanofi, based on 15 analyst estimates. It also says the stock is rated Hold, which fits a cautious tone.MarketBeat consensus snapshot
Thursday chart picture
That backdrop matters because the quoted price on GuruFocus is $42.50, with a 52-week range of $42.28 to $52.68. In that frame, the share price sits close to the lower end of the range.GuruFocus quote note
What Sanofi sells
Sanofi is a global healthcare company with a broad portfolio in immunology, vaccines, and rare diseases. One core product line is Dupixent, its widely used treatment in immunology.
Where the stock trades today
The shares of Sanofi (FR0000127771) trade on Nasdaq at $42.50 as of 06/17/2026.
Key facts on Sanofi stock
- Company: Sanofi S.A.
- ISIN: FR0000127771
- Ticker: SNY
- Venue: Nasdaq
- Price (as of 06/17/2026): $42.50
- Market cap: not live-verifiable
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: not live-verifiable
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
